FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
485 letters match. Newest first.
-
DrugsStellalife, Inc.
FDA told Stellalife its homeopathic oral care gels and rinses are unapproved new drugs sold without FDA approval.
High risk -
DrugsPureRawz
FDA warns PureRawz its tianeptine products are unapproved new drugs sold with drug claims.
High risk -
DrugsFWD Care, Inc. dba FWD
FDA warned telehealth company FWD Care that its website claims for compounded semaglutide and tirzepatide drugs are false or misleading.
Medium -
DrugsExpert Aesthetics
FDA warned Expert Aesthetics over website claims that its compounded semaglutide and tirzepatide are generic Ozempic and Mounjaro.
Low -
DrugsDermacare LLC dba BlueChew
FDA warned BlueChew over website claims that its compounded sildenafil and tadalafil are the same as Viagra and Cialis.
High risk -
DrugsHealthy Living Clinic
FDA warned Healthy Living Clinic that its website misbrands compounded semaglutide by comparing it to Wegovy, Ozempic, and Rybelsus.
Low -
DrugsHims & Hers Health, Inc. dba Hers
FDA warned Hims & Hers (Hers) that its website misleads consumers about compounded semaglutide by implying it is the same as approved Ozempic and Wegovy.
Medium -
DrugsGenLabMeds
GenLabMeds offered compounded retatrutide, semaglutide and tirzepatide online as unapproved, misbranded drugs with false or misleading claims.
High risk -
DrugsThe HCG Institute
FDA warns The HCG Institute over misleading claims for compounded semaglutide sold online.
High risk -
DrugsVitals RX
FDA warned telehealth seller Vitals RX that its website falsely implies compounded semaglutide and tirzepatide are the approved drug Ozempic.
Medium -
DrugsJulyMD
FDA warned JulyMD that its website sold compounded semaglutide with misleading claims comparing it to Wegovy and Ozempic.
High risk -
DrugsSlendid
FDA warned Slendid that its website sells compounded semaglutide and tirzepatide with a false "clinically proven" claim, making the drugs misbranded.
Medium -
DrugsBiopreventative Company LLC dba Biopreventative
FDA told Biopreventative its website claim that compounded tadalafil is "commonly known as Cialis" misbrands the drug.
Low -
DrugsSprout Health Partners LLC dba Sprout Health
FDA warned telehealth seller Sprout Health that its website's claim compounded semaglutide and tirzepatide are FDA-approved makes the drugs misbranded.
Low -
DrugsTRYM Health, Inc. dba TRYM Health
FDA told telehealth seller TRYM Health its website claims for compounded semaglutide and tirzepatide are false and misleading, making the drugs misbranded.
Medium -
DrugsHealBerry
FDA warned HealBerry that claiming compounded semaglutide has the 'same active ingredient as Ozempic and Wegovy' misbrands its drugs.
Medium -
DrugsCosmo Medical Spa dba Cosmo Med Spa
FDA warned Cosmo Med Spa over its website selling compounded semaglutide with claims implying it is FDA-approved Ozempic.
Medium -
DrugsEvoLife Wellness
FDA warned EvoLife Wellness that its website wrongly calls compounded semaglutide and tirzepatide "FDA-Approved," making the drugs misbranded.
Medium -
DrugseDrugstore
FDA warns eDrugstore over claims that compounded tirzepatide is FDA-approved, making drugs misbranded (falsely promoted).
High risk -
DrugsMedClub by Dr. Jenn
FDA warns MedClub by Dr. Jenn over unapproved compounded retatrutide and misleading semaglutide claims on its website.
High risk -
DrugsLumimeds
FDA warns Lumimeds over website claims implying its compounded semaglutide and tirzepatide are FDA-approved.
High risk -
DrugsBody Good Studio
FDA warned Body Good Studio over its website selling compounded semaglutide with a false claim that it matches Ozempic and Wegovy.
High risk -
DrugsCanada Med Stop
Canada Med Stop marketed compounded semaglutide online as FDA-approved and generic, making the drugs misbranded.
Medium -
DrugsAll American Wellness
FDA warned telehealth seller All American Wellness that its website wrongly compares compounded semaglutide and tirzepatide to Ozempic and Mounjaro.
Low -
DrugsIntimate Rose
FDA warned Intimate Rose that its website sells compounded semaglutide and tirzepatide with misleading claims that they match approved drugs.
High risk -
DrugsDr. Gater’s Weight Loss & Wellness
Dr. Gater’s Weight Loss & Wellness marketed compounded semaglutide and tirzepatide with false or misleading FDA-approval and generic-Ozempic claims.
Medium -
DrugsRemedy Meds
FDA warns Remedy Meds that its telehealth site misleadingly labels pharmacy-made semaglutide and tirzepatide with approved-drug comparisons.
Low -
DrugsEA WORKS Limited Liability Company dba Trust Labs
FDA warned Trust Labs it sold unapproved compounded retatrutide and made false FDA-approval claims for semaglutide and tirzepatide online.
High risk -
DrugsFancy Meds, LLC dba Fancy Meds
FDA warns Fancy Meds that its compounded semaglutide and tirzepatide website claims are false or misleading.
Low -
DrugsMatthew Stern, CEO MyStart Health LLC.
FDA warns MyStart Health over 'Generic Ozempic' claims for compounded semaglutide.
Low -
DrugsElite Health Center
FDA warned Elite Health Center that its website falsely implied compounded semaglutide was FDA-approved, making the drugs misbranded.
Low -
DrugsCurex
FDA warned Curex that its website ads for compounded semaglutide and tirzepatide are false or misleading.
High risk -
FoodMericon Industries, Inc.
Mericon Industries sold Florical and Meribin supplements with unapproved drug claims for osteoporosis and serious manufacturing and labeling failures.
High risk -
DrugsGreen Vitality dba Gr33n
FDA warned Green Vitality dba Gr33n that its Jimerito Honey Eye Drops are an unapproved new drug sold with disease-treatment claims.
High risk -
DrugsMy Holistic Honey c/o Shenzhen Qanhai Wanb Express Supply Chain Co., LTD
FDA warned My Holistic Honey that its honey eye drops are an unapproved new drug sold with drug claims.
High risk -
DrugsMel Honey US
FDA warned Mel Honey US that its Jimerito (Melipona) Honey eye drops are an unapproved new drug.
High risk -
DrugsTrew Balance
FDA warned Trew Balance that its Trew Vision CBD Eye Drops are an unapproved new drug sold with disease-treatment claims.
High risk -
DrugsLife Enthusiast Co-op
FDA tells Life Enthusiast Co-op its three eye products sold online are unapproved new drugs.
High risk -
BiologicsInnate Healthcare Institute
FDA warned Arizona clinic Innate Healthcare Institute for selling unapproved umbilical cord stem cells marketed to treat autism.
High risk -
DrugsAlzClipp / UniUni
FDA warns AlzClipp/UniUni that its AlzClipp nasal product is an unapproved new drug and misbranded with false FDA approval claims.
High risk -
DrugsEverlaan Organics, Inc. dba Maple Organics
FDA warns Maple Organics over OTC drug CGMP failures, unapproved new drugs, and misbranding.
High risk -
FoodIndulgeRx Brands, Inc
FDA says IndulgeRx's FightBack nut butters are unapproved new drugs because website and label claims target cancer and disease.
Medium -
DrugsCovalent Medical
FDA warned Covalent Medical that its FOCUS PI post-injection eye drops are an unapproved new drug with claims not allowed for over-the-counter eye products.
Medium -
Drugs7Tabz Retail, LLC
FDA says 7Tabz Retail sells unapproved 7-OH drug products online with drug-like claims.
High risk -
FoodRoyal Diamond Imports, Inc.
FDA warned Royal Diamond Imports that its Roxy 7-OH kratom tablets are unapproved new drugs and its kratom drink mix contains an unsafe food additive.
High risk -
FoodHydroxie, LLC
FDA warned Hydroxie, LLC that its 7-OH tablets, strips, shots, and drink mix are unapproved drugs and an unsafe food additive.
High risk -
DrugsDynamic Blending Specialists, Inc.
FDA cited Dynamic Blending Specialists for manufacturing failures in OTC drugs and an unapproved, misbranded oral antiseptic.
High risk -
FoodM.O.M. Enterprises, LLC
FDA warned M.O.M. Enterprises over adulterated, misbranded baby supplements and unapproved-drug claims for Gripe Water.
High risk -
Drugswww.bigpharmausa.com
FDA warned www.bigpharmausa.com that it sells unapproved and misbranded tramadol and oxycodone opioids to U.S. consumers online.
High risk -
DrugsNefeteri Wellness
FDA says Nefeteri Wellness sells two unapproved colloidal silver vaginal gels promoted to treat infections.
High risk